| NASDAQ : NOVN 2.860 22 Jul 22 00:00 | Change: 0.16 | High: 3.020 |
|---|---|---|
| Change(%): 5.93 | Low: 2.830 |
What is Novan's (NovN) stock price potential in the next 12 months?
Their forecasts range from $2.00 to $16.00. On average, they anticipate Novan's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 93.9% from the stock's current price.
What kind of company is Noven Pharmaceuticals?
Noven Pharmaceuticals, Inc. provides research, development, manufacturing, marketing, and sale of prescription pharmaceutical products. The Company offers vivelle dot estrogen, dentipatch transmucosal patch, estalis estrogen, and progestin transdermal delivery systems. Noven Pharmaceuticals operates in the United States.
How much did Novo (NovN) raise in its IPO?
(NOVN) raised $46 million in an initial public offering on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray acted as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.
Is Novan a profitable company?
Novan has a market capitalization of $67.93 million and generates $4.92 million in revenue each year. The company earns $-29.29 million in net income (profit) each year or ($2.03) on an earnings per share basis. How many employees does Novan have?
Is NOVN stock a good buy?
Novan Inc (NASDAQ:NOVN) The 5 analysts offering 12-month price forecasts for Novan Inc have a median target of 24.00, with a high estimate of 40.00 and a low estimate of 12.00.
Is novan a good stock?
Novan has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Will NOVN go up?
Novan Inc quote is equal to 2.730 USD at 2022-07-21. Based on our forecasts, a long-term increase is expected, the "NOVN" stock price prognosis for 2027-07-16 is 12.316 USD. With a 5-year investment, the revenue is expected to be around +351.12%.
What does novan Inc do?
Novan, Inc. is a medical dermatology company primarily focused on researching, developing and commercializing innovative therapeutic products for skin diseases. Our goal is to deliver safe and efficacious therapies to patients, including developing product candidates where there are unmet medical needs.
Novan to Report Full Year 2021 Financial Results on February 22, 2022
TBJ reveals 2022 Women in Business Lifetime Achievement Award winner
DURHAM, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2021 financial results on Tuesday, February 22nd. Novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. ET that same day.
What is Novan's P/B ratio?
A longtime life sciences industry executive has been named Triangle Business Journal’s 2022 Women in Business Lifetime Achievement Award winner.
What is the P/E ratio of Novan?
Novan has a P/B Ratio of 3.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
Where is Novan located?
The P/E ratio of Novan is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Does Novan pay dividends?
Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 485-8080, via email at [email protected], or via fax at 919-237-9212.
Is Novan a buy or sell company?
Novan does not currently pay a dividend.
Benefiting Patients & Physicians
Novan has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Partnering for Success
Noven is committed to developing and offering products and technologies that meaningfully benefit patients. We offer products in the areas of women’s health and mental health.
Advancing Careers
We have a history of successful industry partnerships and are committed to building long-term, mutually rewarding strategic alliances.
What is Elanco's partnership with JBS?
We seek qualified, talented individuals who share our Values to join the Noven team. To pursue an exciting and rewarding career at Noven, visit our Career Center.
What is fair value in accounting?
GREENFIELD, Ind., June 30, 2021--Today, the Elanco Foundation announces a partnership with the JBS Fund for the Amazon (The Fund) to jointly support the RestaurAmazônia Project , which promotes sustainable farming and environmental conservation in the Amazon.
When will ELAN earnings call end?
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Is Elanco a member of the Greener Cattle Initiative?
ELAN earnings call for the period ending September 30, 2021.